molnupiravir

[COVID-19] UK Authorises Merck’s Antiviral Pill

Nov 4, 2021. by Ekohot Editor

The pill was licensed for adults 18 and older who have tested positive for COVID-19… EKO HOT BLOG reports that Britain has granted a conditional authorization to Merck’s coronavirus antiviral, the first pill shown to successfully treat COVID-19. It is the first country to approve the treatment, although it was not immediately clear how quickly … Read more

COVID-19: Merck Seeks FDA Emergency Use Authorisation for Antiviral Pill

Oct 12, 2021. by Ekohot Editor

COVID-19: Pharmaceutical Giant Seeks FDA Emergency Use Authorization for Antiviral Treatment

Merck seeks FDA emergency use authorization for antiviral pill treatment molnupiravir for COVID-19. Merck has been producing molnupiravir at risk and expects to produce 10 million courses of treatment by the end of 2021. Ekohotblog reports that pharmaceutical giant, Merck, known as MSD outside the US and Canada, and Ridgeback Biotherapeutics, said Monday, October 11, … Read more